A Study to Evaluate the Intra-subject Variability of Brodalumab Pharmacokinetic Parameters in Healthy Subjects

Sponsor ID

20120337

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

brodalumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

Location

Status

Location

Research Site

San Antonio, TX, United States, 78209

Status

Completed